V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290004393 | 290003231 | 1.7 | 78 | Adjuvant (A) | 2018-02-24 | 2018-03-08 | LANREOTIDE | N | N | 290021106 | PAZOPANIB |
| 290004394 | 290003232 | 1.58 | 58 | null | 2015-03-12 | 2015-04-02 | Capecitabine 42days + RT | 2 | N | 290021108 | OCTREOTIDE |
| 290004395 | 290003232 | 1.64 | 0 | Palliative (P) | 2016-07-18 | 2016-07-20 | LANREOTIDE | N | null | 290021108 | EOX |
| 290004396 | 290003233 | 1.66 | 70.7 | Palliative (P) | 2013-07-08 | 2013-07-08 | Irinotecan 14day | 2 | null | 290021110 | MCX |
| 290004397 | 290006476 | 1.82 | null | Curative (C) | 2014-11-10 | 2014-11-10 | LANREOTIDE | 02 | null | 290021112 | CAPECITABINE + RT |
| 290004398 | 290003234 | 1.6 | 81.9 | Palliative (P) | 2017-09-25 | 2017-10-01 | Irinotecan + Modified De Gramont | N | N | 290021114 | RCEOP |
| 290004399 | 290003234 | 1.6 | 70.7 | Not known (9) | 2015-08-20 | 2015-08-24 | FLUOROURACIL | 2 | N | 290021114 | CVD (NEUROENDOCRINE) |
| 290004400 | 290003235 | 1.68 | 0 | Palliative (P) | 2017-04-07 | 2017-04-22 | MCX | N | N | 290021120 | LANREOTIDE |
| 290004401 | 290003236 | 1.6 | 59 | Adjuvant (A) | 2016-02-10 | 2016-02-10 | Ipilimumab | N | N | 290021122 | CAPECITABINE + RT |
| 290004404 | 290003237 | 1.6 | 72 | Palliative (P) | 2015-08-08 | 2015-08-10 | EOX | 02 | N | 290021128 | CETUXIMAB + IRINOTECAN |
| 290004405 | 290003237 | 1.7 | 74.4 | Palliative (P) | 2016-10-18 | 2016-11-01 | OCTREOTIDE | N | N | 290021128 | CAPECITABINE + RT |
| 290004406 | 290003238 | 1.74 | 61 | Palliative (P) | 2016-09-02 | 2016-09-07 | CARBOPLATIN + ETOPOSIDE | N | N | 290021132 | CISPLATIN + FLUOROURACIL |
| 290004407 | 290003239 | 1.69 | null | null | 2015-05-19 | 2015-06-09 | Fluorouracil + Folinic Acid Weekly | N | N | 290021133 | OCTREOTIDE |
| 290004408 | 290003240 | 0 | 77 | Palliative (P) | 2016-03-05 | 2016-03-05 | CAPECITABINE + TEMOZOLOMIDE | Y | N | 290021134 | CARBOPLATIN + PEMETREXED |
| 290004409 | 290003241 | 1.64 | 73 | Curative (C) | 2016-11-29 | 2016-12-13 | Irinotecan + Modified De Gramont | 02 | Y | 290021135 | CISPLATIN + FLUOROURACIL |
| 290004410 | 290003242 | 1.75 | null | Curative (C) | 2016-01-23 | 2016-01-24 | Doxorubicin + Olaratumab | 02 | null | 290021136 | CAPECITABINE + RT |
| 290004411 | 290003243 | 1.56 | null | Neo-adjuvant (N) | 2016-12-08 | 2016-12-27 | Capecitabine + Cisplatin | 02 | N | 290021138 | CAPECITABINE + RT |
| 290004412 | 290003244 | 1.68 | 45 | Curative (C) | 2018-02-17 | 2018-02-17 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 290021139 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004413 | 290003244 | 1.72 | 61.7 | Palliative (P) | 2018-07-08 | 2018-07-18 | Capecitabine | N | N | 290021139 | FLUOROURACIL |
| 290004414 | 290003244 | 1.65 | 75.5 | Adjuvant (A) | 2013-12-22 | 2013-12-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290021139 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004415 | 290003245 | 0 | null | Palliative (P) | 2014-05-27 | 2014-05-27 | LANREOTIDE | N | N | 290021146 | IPILIMUMAB + NIVOLUMAB |
| 290004416 | 290003245 | 1.68 | 53.1 | Palliative (P) | 2014-09-07 | 2014-09-11 | Capecitabine (14 days)+Carboplatin | N | N | 290021146 | MCX |
| 290004417 | 290003246 | 1.76 | 67.3 | Disease modification (D) | 2015-02-27 | 2015-02-27 | Ipilimumab | N | N | 290021149 | CETUXIMAB + RT |
| 290004418 | 290003246 | 1.6 | 64.2 | Palliative (P) | 2016-08-03 | 2016-08-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 290021149 | CAPECITABINE |
| 290004419 | 290003246 | 1.8 | 67.2 | Neo-adjuvant (N) | 2015-07-24 | 2015-07-25 | Trial Unspecified | 2 | N | 290021149 | FLUOROURACIL |
| 290004420 | 290003246 | 1.8 | null | Palliative (P) | 2014-12-14 | 2014-12-16 | Cetuximab + Radiotherapy Load | 2 | N | 290021149 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290004421 | 290003246 | 1.73 | 79.5 | Palliative (P) | 2017-02-03 | 2017-02-21 | Capecitabine 35days + RT | null | N | 290021149 | CAPECITABINE + RT |
| 290004422 | 290003247 | 1.6 | 48.2 | Palliative (P) | 2016-02-21 | 2016-03-01 | Cisplatin + Pemetrexed | Y | N | 290021157 | ECX |
| 290004423 | 290003247 | 1.75 | 57.7 | null | 2013-06-24 | 2013-07-08 | CHOP R | null | null | 290021157 | TRIAL |
| 290004424 | 290003248 | null | 80.9 | Neo-adjuvant (N) | 2017-05-08 | 2017-05-13 | Capecitabine 35days + RT | 02 | N | 290021161 | CHOP |
| 290004425 | 290003249 | 1.6 | 60.2 | Palliative (P) | 2014-10-27 | 2014-11-16 | CISPLATIN + FLUOROURACIL | 02 | N | 290021163 | CISPLATIN + FLUOROURACIL |
| 290004426 | 290003250 | 1.53 | 41.4 | Palliative (P) | 2013-03-10 | 2013-04-01 | GEMCARBO | 2 | N | 290021164 | CISPLATIN + FLUOROURACIL |
| 290004427 | 290003251 | 1.68 | 66.2 | Palliative (P) | 2014-11-11 | 2014-11-24 | Capecitabine 42days + RT | 02 | N | 290021166 | GEMCARBO |
| 290004428 | 290003252 | 1.85 | 79 | null | 2017-11-07 | 2017-11-11 | CETUXIMAB + CISPLATIN + FU | N | null | 290021171 | GEMCARBO |
| 290004429 | 290003253 | 1.77 | 75 | Adjuvant (A) | 2014-06-28 | 2014-07-15 | Trial Unspecified | N | N | 290021172 | CAPECITABINE + RT |
| 290004430 | 290003254 | 1.74 | 89 | Palliative (P) | 2013-11-28 | 2013-12-12 | EOX | 02 | N | 290021174 | CAPECITABINE |
| 290004431 | 290003255 | 1.64 | 68 | Palliative (P) | 2017-09-01 | 2017-10-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290021177 | IRINOTECAN + MDG |
| 290004432 | 290003256 | 1.5 | 67 | null | null | 2016-08-04 | Fluorouracil 96hr infusion+R(4g/m2) | N | Y | 290021180 | CISPLATIN + FLUOROURACIL |
| 290004433 | 290003257 | 1.54 | 61.4 | Adjuvant (A) | 2014-05-04 | 2014-08-01 | CAPECITABINE + RT | N | Y | 290021181 | PLATO TRIAL |
| 290004434 | 290003258 | 1.77 | 57 | null | 2017-08-13 | 2017-08-13 | Cisplatin+Gemcitabine (gallbladder) | 02 | null | 290021183 | OCTREOTIDE |
| 290004435 | 290003259 | 1.64 | 53.8 | Palliative (P) | 2017-11-13 | 2017-12-01 | PEMBROLIZUMAB | 02 | N | 290021184 | CISPLATIN + GEMCITABINE |
| 290004436 | 290003260 | 1.78 | 66 | Disease modification (D) | 2016-01-18 | 2016-02-07 | EOX | 02 | N | 290021185 | LANREOTIDE |
| 290004437 | 290003261 | 1.72 | 53.1 | null | 2011-01-06 | 2014-04-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 290021187 | CISPLATIN + FLUOROURACIL |
| 290004438 | 290003262 | 1.75 | 70.6 | Not known (9) | 2014-11-26 | 2014-12-07 | Rituximab | N | N | 290021189 | CAPECITABINE + RT |
| 290004439 | 290003263 | 1.77 | 110 | Curative (C) | 2018-02-11 | 2018-02-23 | Capecitabine 42days + RT | N | N | 290021191 | CISPLATIN + ETOPOSIDE |
| 290004440 | 290003263 | null | 73 | Palliative (P) | 2017-10-24 | 2017-11-07 | INTERFERON | N | N | 290021191 | CISPLATIN + VINORELBINE |
| 290004441 | 290003264 | 1.68 | 65.2 | Palliative (P) | 2016-01-25 | 2016-01-30 | OCTREOTIDE | N | N | 290021197 | RCEOP |
| 290004442 | 290003265 | 1.61 | 44.1 | Neo-adjuvant (N) | 2013-03-02 | 2013-12-05 | CISPLATIN + FLUOROURACIL | N | N | 290021200 | EOX |
| 290004443 | 290003266 | 1.68 | 77.8 | 5 | 2013-04-21 | 2013-04-21 | Capecitabine | 02 | null | 290021201 | CAPECITABINE + CARBOPLATIN |
| 290004446 | 290003268 | 1.62 | 43 | Curative (C) | 2015-06-18 | 2015-07-17 | PEMBROLIZUMAB | N | Y | 290021207 | TRIAL |